Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network

Simple item page
dc.contributor.authorBeksac, Meral
dc.contributor.departmentTıp Fakültesitr_TR
dc.date.accessioned2020-12-30T12:56:41Z
dc.date.available2020-12-30T12:56:41Z
dc.date.issued2018
dc.description.abstractDuring the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved the treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are representatives of new drug classes, and as such present with very specific side effect profiles. In this review, we summarize these adverse events, provide information on their prevention, and give practical guidance for monitoring of patients and for management of adverse events.tr_TR
dc.description.indexPubmed
dc.identifier.endpage1560tr_TR
dc.identifier.issue7tr_TR
dc.identifier.startpage1542tr_TR
dc.identifier.urihttps://doi.org/10.1038/s41375-018-0040-1tr_TR
dc.identifier.urihttp://hdl.handle.net/20.500.12575/72618
dc.identifier.volume32tr_TR
dc.language.isoentr_TR
dc.relation.isversionof10.1038/s41375-018-0040-1tr_TR
dc.relation.journalLeukemia .tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıtr_TR
dc.subjectMyeloma Networktr_TR
dc.titlePrevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Networktr_TR
dc.typeArticletr_TR

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
41375_2018_Article_40.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Makale
PubMed İndeksli Yayınlar